<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dirros.openscience.si/IzpisGradiva.php?id=28619"><dc:title>The  application of ultrasound sarcopenia index in sarcopenic population</dc:title><dc:creator>Puš,	Katarina	(Avtor)
	</dc:creator><dc:creator>Sarto,	Fabio	(Avtor)
	</dc:creator><dc:creator>Narici,	Marco Vincenzo	(Avtor)
	</dc:creator><dc:creator>Šimunič,	Boštjan	(Avtor)
	</dc:creator><dc:subject>muscle architecture</dc:subject><dc:subject>aging</dc:subject><dc:subject>muscle quality</dc:subject><dc:subject>muscle function</dc:subject><dc:description>Background: Aging leads to progressive motor system decline, which can result in sarcopenia, defined as the age- related loss of muscle mass and function. Architectural changes, epitomized by a decrease in fascicle length (Lf) and muscle thickness (MT), provide a useful signature of sarcopenia. Their ratio (Lf/MT), named ultrasound sarcopenia index (USI), is a new parameter proposed for evaluating changes in muscle geometric proportions associated with muscle atrophy but lacks application in a sarcopenic population. This study aimed to explore vastus lateralis USI in a sarcopenic population. Methods: In a sample of 139 older adults (54% females), recruited from Italy and Slovenia, we assessed muscle architecture using ultrasound imaging to measure Lf, MT, pennation angle (PA), and USI. We assessed handgrip strength, sit-to-stand test, and physical performance with timed up-and-go and gait speed. Appendicular lean mass was assessed with dual x-ray absorptiometry. Sarcopenia was classified using the EWGSOP2 and SDOC classifications. Results: Sarcopenia prevalence was 15.1% and 30.9% when classified by the EWGSOP2 and SDOC classifications, respectively. Differences in muscle architecture were observed between sarcopenic and non-sarcopenic groups, with MT showing the largest effect size (Cohen's d EWGSOP2: 0.86; SDOC:0.77). USI was higher in sarcopenic compared to non-sarcopenic individuals classified with EWGSOP2 (5.33 ± 1.30 vs 4.59 ± 0.94, p = .011, Cohen's d:0.69), confirming its sensitivity in detecting sarcopenia. Conclusion: We showed that increased USI values are associated with sarcopenia. This study shows USI as a sensitive, non-invasive marker for sarcopenia classification, supporting its use in clinical screening and monitoring of muscle changes in older adults.</dc:description><dc:date>2026</dc:date><dc:date>2026-03-26 09:11:56</dc:date><dc:type>Neznano</dc:type><dc:identifier>28619</dc:identifier><dc:language>sl</dc:language><dc:rights>The authors</dc:rights></rdf:Description></rdf:RDF>
